/apple-app-store.png?width=97&name=apple-app-store.png)
/google-play.png?width=88&name=google-play.png)
August 15, 2013 at 1:25 PM
Last week, Jeff Kraws sat down with Rhonda Schaffler at Reuters to discuss opportunities and trends in the biotech space. Mr. Kraws is a veteran Wall Street sell-side analyst with more than 20 years of experience and is also cofounder and CEO of Crystal Research Associates. If you enjoyed the short clip of this interview released earlier this week, the full segment (available below) goes into more detail on individual biotech stocks and the events every investor should be watching out for.
Topics: AtheroNova, Crystal Research Associates, Unilife Corp., biotech, MetaStat, Reuters
February 13, 2013 at 3:14 PM
This morning, Crystal Research's CEO Jeff Kraws was invited to participate in a roundtable discussion to analyze how investors should be reacting to President Obama's State of the Union address. The segment was hosted by Thomson Reuters' Rhonda Schaffler and also featured David Joy, Chief Market Strategist of Ameriprise Financial, and Craig Irwin, Senior Vice President at Wedbush Securities.
Topics: Bridgelux, Crystal Research Associates, nanotechnology, green infrastructure, Unilife Corp., MetaStat
July 31, 2012 at 8:26 AM
Topics: Crystal Research Associates, Newsworthy Events, Unilife Corp., Prefilled Syringe
May 11, 2012 at 9:20 AM
MedPro Safety Products, Inc. (MPSP-OTC.BB) and Unilife Corporation (UNIS-NASDAQ) were featured in the May 2012 edition of Drug Development & Delivery in an article, entitled "Prefilled Syringes - A Container of Choice for Pharma." Drug Development & Delivery interviewed leading players in the prefilled syringe market to learn about their products and how each company is addressing pharma’s needs for safety, ease of use, cost, and product differentiation.
Topics: Unilife Corp., MedPro, Prefilled Syringe
March 16, 2012 at 12:42 PM
Since we first initiated coverage on Unilife (UNIS-NASDAQ) in 2009, we have seen the company grow and accomplish a number of impressive milestones. Unilife has transitioned from a development-stage Australian medical device company to a sizable, commercial-stage, NASDAQ-listed U.S. company.
Topics: Unilife Corp.
/facebook.png)
FACEBOOK/twitter.png)
TWITTER/youtube.png)
YOUTUBE/linkedin.png)
LINKEDIN/slideshare.png)
SLIDESHARE/rss.png)
RSS